Former Texas Governor Rick Perry has emerged as a prominent advocate for ibogaine research through the organization Americans for Ibogaine. The group is pushing for increased federal research funding and a potential reclassification of ibogaine to enable clinical access.
Key Developments
- Federal Advocacy: Americans for Ibogaine is lobbying Congress for dedicated NIH research funding for ibogaine therapy
- Bipartisan Support: The initiative has attracted support from both sides of the aisle, united by the opioid crisis
- Veterans Focus: Perry has highlighted the potential for ibogaine to address the veteran suicide epidemic, with 22 veterans dying by suicide daily
Why This Matters
The opioid crisis has killed over 100,000 Americans annually, and conventional treatments have limited success rates. Ibogaine's ability to interrupt addiction patterns in a single treatment session makes it a compelling candidate for further research.
"We cannot afford to ignore a potential breakthrough treatment while Americans are dying every day." — Rick Perry
The organization is also pushing for FDA-approved clinical trials in the United States, which would be a significant step toward making ibogaine therapy accessible domestically.
Related Articles
Ibogaine Research: Why Progress Is Slow
Ibogaine research moves slowly for structural reasons: drug scheduling, patents, cardiac risk, supply, and blinding, and some of those are changing.
ResearchIbogaine for Fentanyl Addiction: Clinical Protocol, Safety Considerations & Real Outcomes
Ibogaine for Fentanyl Addiction: Clinical Protocol, Safety Considerations & Real Outcomes Author: Dr. JJ Arellano, MD | Published: October 15, 2026 | Read Time: 22 minutes --- The Crisis That Traditional Treatment Can't Solve Alone Jennifer had a legitimate pain prescription aft
Treatment GuidesIbogaine Therapy vs Other Psychedelic Therapies
How ibogaine therapy differs from MDMA, psilocybin, ketamine and ayahuasca in duration, mechanism, risk profile and what each is actually used for.